Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, doubleblind, placebocontrolled trial of goshajinkigan to prevent oxaliplatininduced neuropathy - Kono, T; Hata, T; Morita, S (Cancer Chemother Pharmacol, 2013)
et al.